Clinical characteristics of renal artery stenosis complicated with malignant hypertension
- VernacularTitle:肾动脉狭窄合并恶性高血压的临床特点
- Author:
Luxia ZHANG
;
Mei WANG
;
Haiyan WANG
;
- Publication Type:Journal Article
- Keywords:
Renal artery stenosis;
Malignant hypertension;
Prognosis
- From:
Chinese Journal of Nephrology
1997;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the incidence, clinical characteristics and prognosis of malignant hypertension (MHT) resulted from renal artery stenosis (RAS).Methods Among those diagnosed as RAS by arteriography over a 23 year period (From January 1980 to April 2003), 23 patients complicated with malignant hypertension(MHT) were included. Their etiology, clinical characteristics,treatment and prognosis were analyzed, and compared with those of 46 renal parenchymal MHT and 23 primary MHT cases during in the same period.Results Twenty three patients accounted for 25 8%of MHT cases and 19 5%of RAS cases during the same period.Among 23 patients, atherosclerotic renal artery stenosis (ARAS) and Takayasu arteritis were most commonly seen, and ARAS became the leading cause after 1990.The distinct characteristics of RAS included unilateral small kidney(52 2%), abdominal or flank bruit(17 4%)and azotemia induced by treatment with angiotensin converting enzyme inhibitor(8.7%).Besides, compared with renal parenchymal MHT group, the level of urine protein in RAS with MHT group was less and all decreased to less than 1 g/d after blood pressure was controlled.Furthermore, hematuria was seldom in RAS with MHT group. As for basal renal function, serum creatinine level in the majority in RAS with MHT group was normal, while most patients of the other two groups had elevated or remarkably elevated serum creatinine level.Hypertension was cured in 54 5%of those receiving interventional therapy in RAS with MHT group. During the follow up 3～12 months, only 2 cases in RAS with MHT group were dialysis dependent, who were less than those in other groups.Conclusions RAS is a common cause of secondary MHT, and the percentage of ARAS is increasing. For MHT patients without hematuria and massive proteinuria, screening for renal artery stenosis is strongly recommended. Although prognosis of RAS is comparatively good, early diagnosis and treatment are crucial.
